Capital International Investors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.51B Sell
7,122,275
-11,063,995
-61% -$3.94B 0.59% 47
2025
Q4
$5.95B Sell
18,186,270
-1,006,725
-5% -$319M 0.93% 27
2025
Q3
$5.41B Buy
19,192,995
+282,219
+1% +$81.8M 0.87% 26
2025
Q2
$5.28B Buy
18,910,776
+3,775,911
+25% +$1.07B 0.91% 24
2025
Q1
$4.71B Buy
15,134,865
+2,922,800
+24% +$863M 0.93% 22
2024
Q4
$3.18B Buy
12,212,065
+3,495,503
+40% +$1.04B 0.6% 43
2024
Q3
$2.81B Buy
8,716,562
+337,602
+4% +$110M 0.54% 51
2024
Q2
$2.62B Buy
8,378,960
+1,373,691
+20% +$404M 0.54% 53
2024
Q1
$1.99B Buy
7,005,269
+5,923,915
+548% +$1.73B 0.4% 72
2023
Q4
$311M Buy
1,081,354
+338,515
+46% +$92.2M 0.07% 194
2023
Q3
$200M Buy
742,839
+164,374
+28% +$41M 0.05% 217
2023
Q2
$128M Buy
578,465
+109
+0% +$25.3K 0.03% 268
2023
Q1
$140M Buy
578,356
+182
+0% +$44.7K 0.04% 261
2022
Q4
$152M Buy
578,174
+250
+0% +$67K 0.04% 259
2022
Q3
$130M Buy
577,924
+74
+0% +$17.9K 0.04% 270
2022
Q2
$141M Sell
577,850
-57,138
-9% -$14M 0.04% 266
2022
Q1
$154M Sell
634,988
-1,954,872
-75% -$449M 0.04% 271
2021
Q4
$583M Buy
2,589,860
+235
+0% +$49.6K 0.12% 162
2021
Q3
$551M Buy
2,589,625
+430,393
+20% +$99.1M 0.13% 157
2021
Q2
$526M Buy
2,159,232
+189,782
+10% +$46.7M 0.12% 166
2021
Q1
$490M Sell
1,969,450
-371,136
-16% -$88.6M 0.12% 167
2020
Q4
$538M Sell
2,340,586
-759,446
-24% -$175M 0.15% 148
2020
Q3
$788M Sell
3,100,032
-1,010,388
-25% -$250M 0.24% 106
2020
Q2
$969M Sell
4,110,420
-1,589,967
-28% -$363M 0.32% 82
2020
Q1
$1.16B Buy
5,700,387
+933,191
+20% +$204M 0.47% 52
2019
Q4
$1.15B Sell
4,767,196
-260,127
-5% -$57.3M 0.39% 78
2019
Q3
$973M Sell
5,027,323
-3,972,062
-44% -$762M 0.37% 77
2019
Q2
$1.66B Buy
8,999,385
+39,282
+0.4% +$7.03M 0.66% 42
2019
Q1
$1.7B Sell
8,960,103
-1,646,336
-16% -$314M 0.73% 38
2018
Q4
$2.06B Sell
10,606,439
-486,743
-4% -$95M 1.03% 24
2018
Q3
$2.3B Buy
11,093,182
+8,329,861
+301% +$1.64B 1.05% 23
2018
Q2
$510M Buy
2,763,321
+73
+0% +$12.9K 0.58% 63
2018
Q1
$471M Buy
2,763,248
+83,200
+3% +$15.3M 0.54% 64
2017
Q4
$466M Hold
2,680,048
0.53% 68
2017
Q3
$500M Hold
2,680,048
0.6% 57
2017
Q2
$462M Hold
2,680,048
0.62% 52
2017
Q1
$440M Hold
2,680,048
0.6% 53
2016
Q4
$392M Hold
2,680,048
0.57% 53
2016
Q3
$447M Hold
2,680,048
0.65% 49
2016
Q2
$408M Hold
2,680,048
0.6% 51
2016
Q1
$402M Hold
2,680,048
0.62% 48
2015
Q4
$435M Hold
2,680,048
0.67% 45
2015
Q3
$371M Hold
2,680,048
0.67% 48
2015
Q2
$411M Hold
2,680,048
0.7% 41
2015
Q1
$428M Sell
2,680,048
-64,400
-2% -$10.1M 0.78% 34
2014
Q4
$437M Sell
2,744,448
-83,800
-3% -$13.1M 0.89% 32
2014
Q3
$397M Hold
2,828,248
0.97% 25
2014
Q2
$335M Hold
2,828,248
0.86% 35
2014
Q1
$349M Sell
2,828,248
-156,800
-5% -$19M 0.94% 26
2013
Q4
$341M Sell
2,985,048
-1,224,700
-29% -$139M 1.06% 23
2013
Q3
$471M Sell
4,209,748
-283,400
-6% -$30.7M 2.01% 6
2013
Q2
$443M Buy
+4,493,148
New +$466M 2.02% 4

Other funds holding AMGN

Capital International Investors's AMGN Position: Q1 2026 in Review

Capital International Investors reduced its Amgen (AMGN) stake by 61% in Q1 2026, selling an estimated $3.94B and leaving 7,122,275 shares worth $2.51B. The position accounts for 0.59% of the portfolio, ranked #47.

Capital International Investors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.95B in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capital International Investors held 7,122,275 shares of Amgen worth $2.51B as of Q1 2026.
  • Capital International Investors sold 11,063,995 Amgen shares in Q1 2026, an estimated $3.94B.
  • Amgen made up 0.59% of Capital International Investors's portfolio in Q1 2026, its #47 holding.
  • Capital International Investors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Capital International Investors's Amgen position peaked at $5.95B in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.